心室輔助裝置市場規模、佔有率和成長分析（按產品、流量類型和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，心室輔助裝置市場規模將達到 25.9 億美元，到 2025 年將達到 27.9 億美元，到 2033 年將達到 51.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.9%。

心血管疾病發生率的上升和心臟移植需求的增加正在推動全球心室輔助裝置銷售的成長。人口老化是造成這項需求激增的重要因素。此外，創新心室輔助裝置技術的進步以及研發投入的增加預計將創造新的市場機會。同時，全球醫療費用支出的成長也預計將為相關企業帶來更多收入。全人工心臟的日益普及和接受度將進一步推動市場擴張。然而，諸如裝置高成本、潛在併發症以及嚴格的法規環境等挑戰可能會在長期內抑制需求。總而言之，該市場既具有巨大的成長潛力，也存在著顯著的障礙。

心室輔助裝置市場促進因素

心室輔助裝置市場正經歷強勁的成長勢頭，這主要得益於患者對這些裝置益處的認知不斷提高。隨著越來越多的人意識到心室輔助裝置的潛在益處，例如改善治療效果和提高生活品質，他們越來越願意選擇這些創新解決方案。醫療服務提供者和患者都認知到這些裝置在治療嚴重心臟疾病方面的重要作用，預計這種日益成長的興趣將推動市場成長。認知度的提高，以及對先進治療方案的偏好轉變，可望持續推動市場擴張。

心室輔助裝置市場的限制

心室輔助裝置市場面臨許多限制因素，主要原因是許多開發中國家獲得先進醫療服務的機會有限。這些裝置通常用於心臟移植和人工心臟置換等複雜手術。然而，這些地區醫療基礎設施和資金的匱乏限制了患者獲得此類最先進治療。因此，這些地區的許多患者無法受益於這項救命技術，阻礙了心室輔助裝置市場的收入成長潛力。

心室輔助裝置市場趨勢

在心室輔助裝置 (VAD) 市場，產品小型化正成為日益顯著的市場趨勢，各公司致力於擴大植入覆蓋範圍並提升患者舒適度。開發更小巧、更有效率的組件不僅能幫助製造商應對適應不同患者群體的挑戰，還能提高裝置的整體性能和耐用性。設計和技術的創新至關重要，它能幫助市場參與者在競爭激烈的環境中脫穎而出。隨著醫療機構不斷尋求能夠最佳化治療效果並最大限度減少侵入性手術的先進解決方案，這種對小型化的關注預計將推動市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL 分析
• 總體經濟指標
• 貿易分析
• Start-Ups分析
• 原料分析
• 供應鏈分析
• 定價分析

全球心室輔助裝置市場規模（依產品及複合年成長率分類）（2026-2033 年）

• 左心室輔助裝置
• 右心室輔助裝置
• 雙心室輔助裝置
• 人工心臟

全球心室輔助裝置市場規模（按流量類型和複合年成長率分類）（2026-2033 年）

• 脈動流
• 連續流

全球心室輔助裝置市場規模（按應用及複合年成長率分類）（2026-2033 年）

• BTT
• DT
• 其他

全球心室輔助裝置市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 植入式心室輔助裝置
• 經皮心室輔助裝置

全球心室輔助裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• FineHeart SA
• TELEFLEX INCORPORATED
• BiVACOR
• Abbott
• Berlin Heart
• Cardiac Assist, Inc.
• Jarvik Heart, Inc.
• ReliantHeart, Inc.
• SYNCARDIA SYSTEMS
• FRESENIUS MEDICAL CARE AG & CO. KGAA
• GETINGE
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
• ANGIODROID
• CARDIODYME
• WORLD HEART CORPORATION
• Sun Medical Technology Research Corporation
• CorWave SA
• Windmill Cardiovascular Systems
• Leviticus Cardio
• CardioBridge GmbH

結論與建議

Ventricular Assist Devices Market size was valued at USD 2.59 Billion in 2024 and is poised to grow from USD 2.79 Billion in 2025 to USD 5.13 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The rising prevalence of cardiovascular disorders and the increasing necessity for heart transplants are driving sales growth for ventricular assist devices globally. The aging population significantly contributes to this demand surge. Additionally, advancements in innovative ventricular assist device technology and heightened investment in research and development are poised to create new market opportunities. Moreover, a rise in global healthcare expenditure is expected to enhance revenue generation for these companies. The expanding availability of total artificial hearts and their growing acceptance will further stimulate market expansion. Conversely, challenges such as the high cost of devices, potential complications, and a stringent regulatory environment may constrain demand in the long run. Overall, the market presents both significant growth potential and notable obstacles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Ventricular Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Ventricular Assist Devices Market Segments Analysis

Global Ventricular Assist Devices Market is segmented by Product, Type of Flow, Design, Application, and region. Based on Product, the market is segmented into Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart. Based on Type of Flow, the market is segmented into Pulsatile Flow, Continuous Flow. Based on Design, the market is Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device. Based on Application, the market is segmented into Bridge to Transplant, Destination Therapy, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Ventricular Assist Devices Market

The Ventricular Assist Devices market is experiencing significant momentum driven by increasing awareness among patients regarding the advantages these devices offer. As more individuals learn about the potential benefits of ventricular assist devices, including improved treatment outcomes and enhanced quality of life, their willingness to choose these innovative solutions is rising. This growing interest is expected to propel market growth as healthcare providers and patients alike recognize the critical role these devices play in managing severe heart conditions. The combination of heightened awareness and a shift towards advanced treatment options is likely to sustain ongoing expansion within the market.

Restraints in the Ventricular Assist Devices Market

The Ventricular Assist Devices market faces significant constraints primarily due to the limited availability of advanced medical treatments in many developing nations. These devices are typically utilized in intricate medical procedures, such as heart transplants or the replacement of a heart with an artificial counterpart. However, the lack of established healthcare infrastructure and funding in these regions restricts access to such cutting-edge therapies. As a result, the potential for sales growth in the ventricular assist devices market is hindered, as many patients in these areas remain unable to benefit from these life-saving technologies.

Market Trends of the Ventricular Assist Devices Market

The ventricular assist devices (VAD) market is increasingly trending towards the miniaturization of products, as companies aim to enhance the scope of implantation and patient comfort. By developing smaller and more efficient components, manufacturers can not only address the complexities of fitting devices into a broader range of patients but also improve overall device performance and longevity. Innovations in design and technology are vital, allowing market players to differentiate their offerings in a competitive landscape. This focus on miniaturization is expected to drive growth, as healthcare providers increasingly seek advanced solutions that optimize treatment outcomes while minimizing invasive procedures.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Supply Chain Analysis
• Pricing Analysis

Global Ventricular Assist Devices Market Size by Product & CAGR (2026-2033)

• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Bi-Ventricular Assist Device
• Total Artificial Heart

Global Ventricular Assist Devices Market Size by Type of Flow & CAGR (2026-2033)

• Pulsatile Flow
• Continuous Flow

Global Ventricular Assist Devices Market Size by Application & CAGR (2026-2033)

• Bridge to Transplant
• Destination Therapy
• Others

Global Ventricular Assist Devices Market Size by Design & CAGR (2026-2033)

• Market Overview Implantable Ventricular Assist Device
• Transcutaneous Ventricular Assist Device

Global Ventricular Assist Devices Market Size & CAGR (2026-2033)

• North America, (Product, Type of Flow, Application, Design)
  • US
  • Canada
• Europe, (Product, Type of Flow, Application, Design)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Type of Flow, Application, Design)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Type of Flow, Application, Design)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Type of Flow, Application, Design)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• FineHeart SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TELEFLEX INCORPORATED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Assist, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNCARDIA SYSTEMS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FRESENIUS MEDICAL CARE AG & CO. KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GETINGE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIODROID
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARDIODYME
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WORLD HEART CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Medical Technology Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation